Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,000 | 118,000 | 57,000 | -85,000 | 173,000 |
| Depreciation Amortization | 19,000 | 12,000 | 6,000 | 21,000 | 17,000 |
| Accounts receivable | -26,000 | -8,000 | 7,000 | -21,000 | 2,000 |
| Accounts payable and accrued liabilities | 91,000 | 60,000 | 30,000 | -98,000 | -75,000 |
| Other Working Capital | 61,000 | -147,000 | -62,000 | 125,000 | -122,000 |
| Other Operating Activity | -114,000 | -90,000 | -74,000 | 54,000 | 19,000 |
| Operating Cash Flow | $-34,000 | $-55,000 | $-36,000 | $-4,000 | $14,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -40,000 | -36,000 | -33,000 | -245,000 | -233,000 |
| PPE Investments | -128,000 | -126,000 | -125,000 | -5,000 | -4,000 |
| Sale Of Investment | 95,000 | 64,000 | 36,000 | 27,000 | 15,000 |
| Purchase Sale Intangibles | -31,000 | -5,000 | -5,000 | N/A | 1,000 |
| Other Investing Activity | -31,000 | -5,000 | -5,000 | 0 | 1,000 |
| Investing Cash Flow | $-104,000 | $-103,000 | $-127,000 | $-223,000 | $-221,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -12,000 | -11,000 | -11,000 | -3,000 | -2,000 |
| Common Stock Issued | 4,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Common Stock Repurchased | -11,000 | -11,000 | -11,000 | -90,000 | -66,000 |
| Other Financing Activity | -6,000 | -4,000 | -2,000 | -9,000 | -6,000 |
| Financing Cash Flow | $-25,000 | $-24,000 | $-22,000 | $-100,000 | $-72,000 |
| Exchange Rate Effect | -1,000 | N/A | -1,000 | -1,000 | -2,000 |
| Beginning Cash Position | 774,000 | 774,000 | 774,000 | 1,102,000 | 1,102,000 |
| End Cash Position | 610,000 | 592,000 | 588,000 | 774,000 | 821,000 |
| Net Cash Flow | $-164,000 | $-182,000 | $-186,000 | $-328,000 | $-281,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,000 | -55,000 | -36,000 | -4,000 | 14,000 |
| Capital Expenditure | -128,000 | -126,000 | -125,000 | -5,000 | -4,000 |
| Free Cash Flow | -162,000 | -181,000 | -161,000 | -9,000 | 10,000 |